Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Oct;66(4):813–820. doi: 10.1172/JCI109919

Effect of somatostatin on ion transport in the rat colon.

K Dharmsathaphorn, L Racusen, J W Dobbins
PMCID: PMC371656  PMID: 6106653

Abstract

The effect of somatostatin (SRIF) on ion transport was determined in the rat colon in vitro. SRIF produced a sustained decrease in the short circuit current (Isc) (-0.8 +/- 0.1 mueq/h x cm2) and increased net Cl absorption (0.9 +/- 0.3 mueq/h x cm2). The threshold effect of SRIF on Isc was observed at 6 nM. 10 microM serotonin decreased net Na absorption (-2.6 +/- 0.4 mueq/h x cm2), net Cl absorption (-3.6 +/- 0.5 mueq/h x cm2) and increased Isc (0.7 +/- 0.1 mueq/h x cm2); these changes were totally blocked by 0.1 microM SRIF. SRIF completely blocked net Cl secretion induced by 10 mM theophylline (-2.5 +/- 0.7 to +4.1 +/- 2.0 muq/h x cm2) and partially blocked theophylline-induced inhibition of net Na absorption (0.7 +/- 0.5 to 2.1 +/- 0.4 mueq/h x cm2). SRIF also blocked prostaglandin E1 (PGE1) induced increase in potential difference and Isc (P < 0.001). Mucosal cyclic AMP levels were increased by theophylline and PGE1 but not by serotonin. SRIF had no effect on basal or theophylline- and PGE1-stimulated cyclic AMP levels. These results indicate that SRIF blocks both cyclic AMP and noncyclic AMP mediated changes in ion secretion and suggest that SRIF is acting at a step in the secretory process beyond the formation of cyclic AMP.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bicknell R. J., Schofield J. G. Mechanism of action of somatostatin: inhibition of ionophore A23187-induced release of growth hormone from dispersed bovine pituitary cells. FEBS Lett. 1976 Sep 15;68(1):23–26. doi: 10.1016/0014-5793(76)80395-x. [DOI] [PubMed] [Google Scholar]
  2. Binder H. J., Rawlins C. L. Electrolyte transport across isolated large intestinal mucosa. Am J Physiol. 1973 Nov;225(5):1232–1239. doi: 10.1152/ajplegacy.1973.225.5.1232. [DOI] [PubMed] [Google Scholar]
  3. Carter R. F., Bitar K. N., Zfass A. M., Makhlouf G. M. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat. Gastroenterology. 1978 Apr;74(4):726–730. [PubMed] [Google Scholar]
  4. Davis G. R., Camp R. C., Raskin P., Krejs G. J. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome. Gastroenterology. 1980 Feb;78(2):346–349. [PubMed] [Google Scholar]
  5. Dharmsathaphorn K., Sherwin R. S., Cataland S., Jaffe B., Dobbins J. Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Intern Med. 1980 Jan;92(1):68–69. doi: 10.7326/0003-4819-92-1-68. [DOI] [PubMed] [Google Scholar]
  6. Donowitz M., Binder H. J. Jejunal fluid and electrolyte secretion in carcinoid syndrome. Am J Dig Dis. 1975 Dec;20(12):1115–1122. doi: 10.1007/BF01070754. [DOI] [PubMed] [Google Scholar]
  7. Frizzell R. A. Active chloride secretion by rabbit colon: calcium-dependent stimulation by ionophore A23187. J Membr Biol. 1977 Jun 30;35(2):175–187. doi: 10.1007/BF01869948. [DOI] [PubMed] [Google Scholar]
  8. Harper J. F., Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975;1(4):207–218. [PubMed] [Google Scholar]
  9. Ilundain A., Naftalin R. J. Role of Ca(2+)-dependent regulator protein in intestinal secretion. Nature. 1979 May 31;279(5712):446–448. doi: 10.1038/279446a0. [DOI] [PubMed] [Google Scholar]
  10. Jager R. M., Polk H. C., Jr Carcinoid apudomas. Curr Probl Cancer. 1977 May;1(11):1–53. doi: 10.1016/s0147-0272(77)80011-1. [DOI] [PubMed] [Google Scholar]
  11. Schofield J. G., Bicknell R. J. Effects of somatostatin and verapamil on growth hormone release and 45Ca fluxes. Mol Cell Endocrinol. 1978 Jan;9(3):255–268. doi: 10.1016/0303-7207(78)90068-0. [DOI] [PubMed] [Google Scholar]
  12. Wilander E., Portela-Gomes G., Grimelius L., Lundqvist G., Skoog V. Enteroglucagon and substance P-like immunoreactivity in argentaffin and argyrophil rectal carcinoids. Virchows Arch B Cell Pathol. 1977 Oct 27;25(2):117–124. doi: 10.1007/BF02889426. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES